Erratum: Design and synthesis of amphiphilic xanthone-based, membrane-targeting antimicrobials with improved membrane selectivity (Journal of Medicinal Chemistry (2013) 56 (2359-2373) DOI: 10.1021/jm301683j);Design and synthesis of amphiphilic xanthone-based, membrane-targeting antimicrobials with improved membrane selectivity

Journal of Medicinal Chemistry

Volumn 56, Issue 6, 2013, Pages 2359-2373

  Zou, Hanxun ^a,b   Koh, Jun Jie ^a,c   Li, Jianguo ^a,d   Qiu, Shengxiang ^e   Aung, Thet Tun ^a   Lin, Huifen ^a   Lakshminarayanan, Rajamani ^a,h   Dai, Xiaoping ^e   Tang, Charles ^f   Lim, Fang Hui ^a,g   Zhou, Lei ^a   Tan, Ai Ling ^f   Verma, Chandra ^a,d,g,i   Tan, Donald T H ^a,c   Chan, Hardy Sze On ^g   Saraswathi, Padmanabhan ^a   Cao, Derong ^b   Liu, Shouping ^a,h   Beuerman, Roger W ^a,h  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d BIOINFORMATICS INSTITUTE   (Singapore)

^e SOUTH CHINA INSTITUTE OF BOTANY   (China)

^f SINGAPORE GENERAL HOSPITAL   (Singapore)

^g NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^h DUKE NUS MEDICAL SCHOOL   (Singapore)

ⁱ NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA MANGOSTIN; AM 0016; AMINE; AMPHOPHILE; ANTIINFECTIVE AGENT; CARBON; HYDROXYL GROUP; MOLECULAR SCAFFOLD; UNCLASSIFIED DRUG; WATER; XANTHONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; DRUG CONFORMATION; DRUG DESIGN; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; GRAM POSITIVE BACTERIUM; HYDROPHOBICITY; MOLECULAR DYNAMICS; NONHUMAN; PKA;

EID: 84875731528     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm400514x     Document Type: Erratum

References (79)

1. Cosgrove, S. E.; Qi, Y.; Kaye, K. S.; Harbarth, S.; Karchmer, A. W.; Carmeli, Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges Infect. Control Hosp. Epidemiol. 2005, 26, 166-174
2. Xiao, Y. H.; Giske, C. G.; Wei, Z. Q.; Shen, P.; Heddini, A.; Li, L. J. Epidemiology and characteristics of antimicrobial resistance in China Drug. Resist. Update 2011, 14, 236-250
3. Levy, S. B.; Marshall, B. Antibacterial resistance worldwide: causes, challenges and responses Nature Med. 2004, 10, S122-129
4. Resch, A.; Wilke, M.; Fink, C. The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals Eur. J. Health Econ. 2009, 10, 287-297
5. Hanberger, H.; Walther, S.; Leone, M.; Barie, P. S.; Rello, J.; Lipman, J.; Marshall, J. C.; Anzueto, A.; Sakr, Y.; Pickkers, P.; Felleiter, P.; Engoren, M.; Vincent, J. L. Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study Int. J. Antimicrob. Agents 2011, 38, 331-335
6. Hidron, A. I.; Edwards, J. R.; Patel, J.; Horan, T. C.; Sievert, D. M.; Pollock, D. A.; Fridkin, S. K. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007 Infect. Control Hosp. Epidemiol. 2008, 29, 996-1011
7. Rozen, D. E.; McGee, L.; Levin, B. R.; Klugman, K. P. Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae Antimicrob. Agents Chemother. 2007, 51, 412-416
8. Meka, V. G.; Gold, H. S. Antimicrobial resistance to linezolid Clin. Infect. Dis. 2004, 39, 1010-1015
9. Hsu, L. Y.; Leong, M.; Balm, M.; Chan, D. S.; Huggan, P.; Tan, T. Y.; Koh, T. H.; Hon, P. Y.; Ng, M. M. Six cases of daptomycin-non-susceptible Staphylococcus aureus bacteraemia in Singapore J. Med. Microbiol. 2010, 59, 1509-1513
10. Koh, J.-J.; Qiu, S.; Zou, H.; Lakshminarayanan, R.; Li, J.; Zhou, X.; Tang, C.; Saraswathi, P.; Verma, C.; Tan, D. T. H.; Tan, A. L.; Liu, S.; Beuerman, R. W. Rapid bactericidal action of alpha-mangostin against MRSA as an outcome of membrane targeting Biochim. Biophys. Acta 2013, 1828, 834-844
11. Hurdle, J. G.; O'Neill, A. J.; Chopra, I.; Lee, R. E. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections Nature Rev. Microbiol. 2011, 9, 62-75
12. Eun, Y. J.; Foss, M. H.; Kiekebusch, D.; Pauw, D. A.; Westler, W. M.; Thanbichler, M.; Weibel, D. B. DCAP: A Broad-Spectrum Antibiotic That Targets the Cytoplasmic Membrane of Bacteria J. Am. Chem. Soc. 2012, 134, 11322-11325
13. Bai, Y.; Liu, S.; Li, J.; Lakshminarayanan, R.; Pasmanabhan, S.; Tang, C.; Ho, D.; Verma, C.; Beuerman, R. W.; Pervushin, K. Progressive structuring of a branched antimicrobial peptide on the path to the inner membrane target J. Biol. Chem. 2012, 287, 26606-26617
14. Shai, Y. Mode of action of membrane active antimicrobial peptides Biopolymers 2002, 66, 236-248
15. Vooturi, S. K.; Firestine, S. M. Synthetic membrane-targeted antibiotics Curr. Med. Chem. 2010, 17, 2292-300
16. Wimley, W. C. Describing the mechanism of antimicrobial peptide action with the interfacial activity model ACS Chem. Biol. 2010, 5, 905-917
17. Epand, R. M.; Vogel, H. J. Diversity of antimicrobial peptides and their mechanisms of action Biochim. Biophys. Acta 1999, 1462, 11-28
18. Brogden, K. A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nature Rev. Microbiol. 2005, 3, 238-250
19. Hancock, R. E. W. Host Defence (Cationic) Peptides. What is Their Future Clinical Potential? Drugs. 1999, 57, 469-473
20. Ishitsuka, Y.; Arnt, L.; Majewski, J.; Frey, S.; Ratajczek, M.; Kjaer, K.; Tew, G. N.; Lee, K. Y. Amphiphilic poly(phenyleneethynylene)s can mimic antimicrobial peptide membrane disordering effect by membrane insertion J. Am. Chem. Soc. 2006, 128, 13123-13129
21. Tew, G. N.; Clements, D.; Tang, H.; Arnt, L.; Scott, R. W. Antimicrobial activity of an abiotic host defense peptide mimic Biochim. Biophys. Acta 2006, 1758, 1387-1392
22. Ding, B.; Guan, Q.; Walsh, J. P.; Boswell, J. S.; Winter, T. W.; Winter, E. S.; Boyd, S. S.; Li, C.; Savage, P. B. Correlation of the antibacterial activities of cationic peptide antibiotics and cationic steroid antibiotics J. Med. Chem. 2002, 45, 663-669
23. Su, Y.; DeGrado, W. F.; Hong, M. Orientation, dynamics, and lipid interaction of an antimicrobial arylamide investigated by 19F and 31P solid-state NMR spectroscopy J. Am. Chem. Soc. 2010, 132, 9197-205
24. Hansen, T.; Alst, T.; Havelkova, M.; Strom, M. B. Antimicrobial activity of small beta-peptidomimetics based on the pharmacophore model of short cationic antimicrobial peptides J. Med. Chem. 2010, 53, 595-606
25. Isaksson, J.; Brandsdal, B. O.; Engqvist, M.; Flaten, G. E.; Svendsen, J. S.; Stensen, W. A synthetic antimicrobial peptidomimetic (LTX 109): stereochemical impact on membrane disruption J. Med. Chem. 2011, 54, 5786-5795
26. Schmidt, E. J.; Boswell, J. S.; Walsh, J. P.; Schellenberg, M. M.; Winter, T. W.; Li, C.; Allman, G. W.; Savage, P. B. Activities of cholic acid-derived antimicrobial agents against multidrug-resistant bacteria J. Antimicrob. Chemother. 2001, 47, 671-674
27. Hyz, K.; Kawecki, R.; Misior, A.; Bocian, W.; Bednarek, E.; Sitkowski, J.; Kozerski, L. Genistein binding mode to doubly nicked dumbbell DNA. Dynamic and diffusion ordered NMR study J. Med. Chem. 2011, 54, 8386-8393
28. Johnson, J. J.; Petiwala, S. M.; Syed, D. N.; Rasmussen, J. T.; Adhami, V. M.; Siddiqui, I. A.; Kohl, A. M.; Mukhtar, H. alpha-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth Carcinogenesis 2012, 33, 413-419
29. Jung, H. A.; Su, B. N.; Keller, W. J.; Mehta, R. G.; Kinghorn, A. D. Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen) J. Agric. Food. Chem. 2006, 54, 2077-2082
30. Hall, H. K., Jr. Correlation of the Base Strengths of Amines J. Am. Chem. Soc. 1957, 79, 5441-5444
31. Salvatore, R. N.; Yoon, C. H.; Jung, K. W. Synthesis of secondary amines Tetrahedron 2001, 57, 7785-7781
32. Clayden, J.; Greeves, N.; Warren, S.; Wothers, P. Organic Chemistry; Oxford University Press: Oxford, UK, 2001; p 437.
33. Nikaido, H. Molecular basis of bacterial outer membrane permeability revisited Microbiol. Mol. Biol. Rev. 2003, 67, 593-656
34. Vaara, M. Agents that increase the permeability of the outer membrane Microbiol. Rev. 1992, 56, 395-411
35. Savage, P. B. Multidrug-resistant bacteria: overcoming antibiotic permeability barriers of Gram-negative bacteria Ann. Med. 2001, 33, 167-171
36. Djouhri-Bouktab, L.; Vidal, N.; Rolain, J. M.; Brunel, J. M. Synthesis of New 3,20-Bispolyaminosteroid Squalamine Analogues and Evaluation of Their Antimicrobial Activities J. Med. Chem. 2011, 54, 7417-7421
37. Schofield, K.; Grimmett, M. R.; Keene, B. R. T. Heteroaromatic Nitrogen Compounds:The Azoles; Cambridge University Press: London, 1976; pp 281-284.
38. Dharmaratne, H. R.; Sakagami, Y.; Piyasena, K. G.; Thevanesam, V. Antibacterial activity of xanthones from Garcinia mangostana (L.) and their structure-activity relationship studies Nat. Prod. Res. 2012, 1-4
39. Vooturi, S. K.; Cheung, C. M.; Rybak, M. J.; Firestine, S. M. Design, synthesis, and structure-activity relationships of benzophenone-based tetraamides as novel antibacterial agents J. Med. Chem. 2009, 52, 5020-5031
40. Partition Coefficient (n -Octanol/Water), HPLC Method, Organisation for Economic Co-operation and Development, Test No. 117; OECD Publishing: Paris, 2004; p 11.
41. Liu, S.; Zhou, L.; Chen, L.; Dastidar, S. G.; Verma, C.; Li, J.; Tan, D.; Beuerman, R. Effect of structural parameters of peptides on dimer formation and highly oxidized side products in the oxidation of thiols of linear analogues of human beta-defensin 3 by DMSO J. Pept. Sci. 2009, 15, 95-106
42. Zhou, L.; Liu, S. P.; Chen, L. Y.; Li, J.; Ong, L. B.; Guo, L.; Wohland, T.; Tang, C. C.; Lakshminarayanan, R.; Mavinahalli, J.; Verma, C.; Beuerman, R. W. The structural parameters for antimicrobial activity, human epithelial cell cytotoxicity and killing mechanism of synthetic monomer and dimer analogues derived from hBD3 C-terminal region Amino Acids 2011, 40, 123-133
43. Hiramatsu, K.; Hanaki, H.; Ino, T.; Yabuta, K.; Oguri, T.; Tenover, F. C. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility J. Antimicrob. Chemother. 1997, 40, 135-136
44. Grohs, P.; Kitzis, M. D.; Gutmann, L. In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus Antimicrob. Agents Chemother. 2003, 47, 418-420
45. Chin, J. N.; Rybak, M. J.; Cheung, C. M.; Savage, P. B. Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus Antimicrob. Agents Chemother. 2007, 51, 1268-1273
46. Clardy, J.; Fischbach, M. A.; Walsh, C. T. New antibiotics from bacterial natural products Nature Biotechnol. 2006, 24, 1541-1550
47. Zasloff, M. Antimicrobial peptides of multicellular organisms Nature. 2002, 415, 389-395
48. Farrell, D. J.; Robbins, M.; Rhys-Williams, W.; Love, W. G. Investigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage study Antimicrob. Agents Chemother. 2011, 55, 1177-1181
49. von Nussbaum, F.; Brands, M.; Hinzen, B.; Weigand, S.; Habich, D. Antibacterial natural products in medicinal chemistry-exodus or revival? Angew. Chem., Int. Ed. Engl. 2006, 45, 5072-5129
50. Wu, M.; Hancock, R. E. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane J. Biol. Chem. 1999, 274, 29-35
51. Rathinakumar, R.; Walkenhorst, W. F.; Wimley, W. C. Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity J. Am. Chem. Soc. 2009, 131, 7609-7617
52. Roth, B. L.; Poot, M.; Yue, S. T.; Millard, P. J. Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain Appl. Environ. Microbiol. 1997, 63, 2421-2431
53. Yenugu, S.; Hamil, K. G.; Radhakrishnan, Y.; French, F. S.; Hall, S. H. The androgen-regulated epididymal sperm-binding protein, human beta-defensin 118 (DEFB118) (formerly ESC42), is an antimicrobial beta-defensin Endocrinology 2004, 145, 3165-3173
54. Cotroneo, N.; Harris, R.; Perlmutter, N.; Beveridge, T.; Silverman, J. A. Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus Antimicrob. Agents Chemother. 2008, 52, 2223-2225
55. Zhao, W.; Rog, T.; Gurtovenko, A. A.; Vattulainen, I.; Karttunen, M. Role of phosphatidylglycerols in the stability of bacterial membranes Biochimie 2008, 90, 930-938
56. Som, A.; Tew, G. N. Influence of lipid composition on membrane activity of antimicrobial phenylene ethynylene oligomers J. Phys. Chem. B 2008, 112, 3495-3502
57. Penha, F. M.; Rodrigues, E. B.; Maia, M.; Furlani, B. A.; Regatieri, C.; Melo, G. B.; Magalhaes, O., Jr.; Manzano, R.; Farah, M. E. Retinal and ocular toxicity in ocular application of drugs and chemicals-part II: retinal toxicity of current and new drugs Ophthalmic Res. 2010, 44, 205-224
58. Etter, J. C.; Gloor, S.; Mayer, J. M. The adverse effects of local anesthetics on the eye in the development of ocular irritation test Pharm. Acta Helv. 1992, 67, 242-249
59. Etter, J. C.; Wildhaber, A. Biopharmaceutical test of ocular irritation in the mouse Food. Chem. Toxicol. 1985, 23, 321-323
60. Furrer, P.; Plazonnet, B.; Mayer, J. M.; Gurny, R. Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants Int. J. Pharm. 2000, 207, 89-98
61. Alfonso, E. C.; Albert, D. M.; Kenyon, K. R.; Robinson, N. L.; Hanninen, L.; D'Amico, D. J. In vitro toxicity of gentamicin to corneal epithelial cells Cornea 1990, 9, 55-61
62. Nakamura, M.; Nishida, T.; Mishima, H.; Otori, T. Effects of antimicrobials on corneal epithelial migration Curr. Eye Res. 1993, 12, 733-740
63. Petroutsos, G.; Guimaraes, R.; Giraud, J.; Pouliquen, Y. Antibiotics and corneal epithelial wound healing Arch. Ophthalmol. 1983, 101, 1775-1778
64. Mallari, P. L.; McCarty, D. J.; Daniell, M.; Taylor, H. Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis Am. J. Ophthalmol. 2001, 131, 131-133
65. Konishi, M.; Yamada, M.; Mashima, Y. Corneal ulcer associated with deposits of norfloxacin Am. J. Ophthalmol. 1998, 125, 258-260
66. Eiferman, R. A.; Snyder, J. P.; Nordquist, R. E. Ciprofloxacin microprecipitates and macroprecipitates in the human corneal epithelium J. Cataract Refract. Surg. 2001, 27, 1701-1702
67. Pini, A.; Giuliani, A.; Falciani, C.; Fabbrini, M.; Pileri, S.; Lelli, B.; Bracci, L. Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity J.Pept. Sci. 2007, 13, 393-399
68. Zanetti, M.; Gennaro, R.; Skerlavaj, B.; Tomasinsig, L.; Circo, R. Cathelicidin Peptides as Candidates for a Novel Class of Antimicrobials Curr. Pharm. Des. 2002, 8, 779-793
69. Morino, T.; Sano, K.; Hara, H.; Motoyama, K.; Lizuka, K.; Hara, T.; Matsumoto, K.; Yamamoto, H. Toxicological studies on isepamicin (HAPA-B). I. Acute toxicity test in the mouse, rat and dog Jpn. J. Antibiot. 1986, 12, 3164-3178
70. Liu, S. P.; Zhou, L.; Li, J.; Suresh, A.; Verma, C.; Foo, Y. H.; Yap, E. P. H.; Tan, D. T. H.; Beuerman, R. W. Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells ChemBioChem 2008, 9, 964-973
71. Malde, A. K.; Zuo, L.; Breeze, M.; Stroet, M.; Poger, D.; Nair, P. C.; Oostenbrink, C.; Mark, A. E. An Automated Force Field Topology Builder (ATB) and Repository: Version 1.0 J. Chem. Theory Comput. 2011, 7, 4026-4037
72. Lemkul, J. A.; Allen, W. J.; Bevan, D. R. Practical considerations for building GROMOS-compatible small-molecule topologies J. Chem. Inf. Model. 2010, 50, 2221-2235
73. Berendsen, H.; Postma, J.; Gunsteren, W. v.; Hermans, J. In Intermolecular Forces; Pullman, B., Ed.; Reidel: Dordrecht, The Netherlands, 1981.
74. Frantz, J. M.; Dupuy, B. M.; Kaufman, H. E.; Beuerman, R. W. The effect of collagen shields on epithelial wound healing in rabbits Am. J. Ophthalmol. 1989, 108, 524-528
75. Brazzell, R. K.; Stern, M. E.; Aquavella, J. V.; Beuerman, R. W.; Baird, L. Human recombinant epidermal growth factor in experimental corneal wound healing Invest. Ophthalmol. Vis. Sci. 1991, 32, 336-340
76. Crosson, C. E.; Klyce, S. D.; Beuerman, R. W. Epithelial wound closure in the rabbit cornea. A biphasic process Invest. Ophthalmol. Vis. Sci. 1986, 27, 464-473
77. Reidy, J. J.; Zarzour, J.; Thompson, H. W.; Beuerman, R. W. Effect of topical beta blockers on corneal epithelial wound healing in the rabbit Br. J. Ophthalmol. 1994, 78, 377-380
78. Gad, S. C.; Chengelis, C. P. Acute Toxicology Testing, 2nd ed.; Elsevier Inc.: New York, 1998; pp 221-256.
79. Kratz, F.; Ehling, G.; Kauffmann, H. M.; Unger, C. Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH), an albumin-binding prodrug of the anticancer agent doxorubicin Hum. Exp. Toxicol. 2007, 26, 19-35